NCT01824433View on ClinicalTrials.gov

Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

March 7, 2013

Primary Completion Date

March 16, 2017

Study Completion Date

March 16, 2017

Conditions

Major Depression

Interventions

DRUG

venlafaxine

venlafaxine 75-225mg qd

DRUG

fluoxetine

fluoxetine 20-60mg qd

Trial Locations (1)

100088

Beijing Anding Hospital, Beijing

All Listed Sponsors

lead

Capital Medical University

OTHER

NCT01824433 - Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression | Biotech Hunter | Biotech Hunter